Monocuerpo (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Monocuerpo" in Spanish language version.

refsWebsite

Global rank Spanish rank

4^th place

4^th place

2^nd place

2^nd place

610^th place

332^nd place

doi.org

dx.doi.org

«The fibronectin type III domain as a scaffold for novel binding proteins». J. Mol. Biol. 284: 1141-51. December 1998. PMID 9837732. doi:10.1006/jmbi.1998.2238.
«Target-binding proteins based on the 10th human fibronectin type III domain (¹⁰Fn3)». Meth. Enzymol. 503: 135-56. 2012. PMID 22230568. doi:10.1016/B978-0-12-396962-0.00006-9.
«Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold». J. Mol. Biol. 415: 393-405. 2012. PMC 3260337. PMID 22198408. doi:10.1016/j.jmb.2011.12.019.
«A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain». Nat. Struct. Mol. Biol. 17: 519-27. 2010. PMC 2926940. PMID 20357770. doi:10.1038/nsmb.1793.
«Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design». Proc. Natl. Acad. Sci. U.S.A. 108: 7751-6. May 2011. PMC 3093456. PMID 21518904. doi:10.1073/pnas.1102294108.
«Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis». Cell 147: 306-19. 2011. PMC 3202669. PMID 22000011. doi:10.1016/j.cell.2011.08.046.
«Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains». Proc. Natl. Acad. Sci. U.S.A. 110: 14924-9. 2013. PMC 3773763. PMID 23980151. doi:10.1073/pnas.1303640110.
«Proof of dual-topology architecture of Fluc F- channels with monobody blockers». Nat Commun 5: 5120. 2014. PMC 4265568. PMID 25290819. doi:10.1038/ncomms6120.
«Directed evolution of high-affinity antibody mimics using mRNA display». Chem. Biol. 9: 933-42. 2002. PMID 12204693. doi:10.1016/s1074-5521(02)00187-4.
«FN3: a new protein scaffold reaches the clinic». Drug Discov. Today 14 (19–20): 949-55. July 2009. PMID 19576999. doi:10.1016/j.drudis.2009.06.007.
«Monobodies: antibody mimics based on the scaffold of the fibronectin type III domain». Methods Mol. Biol. 352: 95-109. 2007. PMID 17041261. doi:10.1385/1-59745-187-8:95.

elsevier.com

linkinghub.elsevier.com

«FN3: a new protein scaffold reaches the clinic». Drug Discov. Today 14 (19–20): 949-55. July 2009. PMID 19576999. doi:10.1016/j.drudis.2009.06.007.

nih.gov

ncbi.nlm.nih.gov

«The fibronectin type III domain as a scaffold for novel binding proteins». J. Mol. Biol. 284: 1141-51. December 1998. PMID 9837732. doi:10.1006/jmbi.1998.2238.
«Target-binding proteins based on the 10th human fibronectin type III domain (¹⁰Fn3)». Meth. Enzymol. 503: 135-56. 2012. PMID 22230568. doi:10.1016/B978-0-12-396962-0.00006-9.
«Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold». J. Mol. Biol. 415: 393-405. 2012. PMC 3260337. PMID 22198408. doi:10.1016/j.jmb.2011.12.019.
«A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain». Nat. Struct. Mol. Biol. 17: 519-27. 2010. PMC 2926940. PMID 20357770. doi:10.1038/nsmb.1793.
«Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design». Proc. Natl. Acad. Sci. U.S.A. 108: 7751-6. May 2011. PMC 3093456. PMID 21518904. doi:10.1073/pnas.1102294108.
«Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis». Cell 147: 306-19. 2011. PMC 3202669. PMID 22000011. doi:10.1016/j.cell.2011.08.046.
«Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains». Proc. Natl. Acad. Sci. U.S.A. 110: 14924-9. 2013. PMC 3773763. PMID 23980151. doi:10.1073/pnas.1303640110.
«Proof of dual-topology architecture of Fluc F- channels with monobody blockers». Nat Commun 5: 5120. 2014. PMC 4265568. PMID 25290819. doi:10.1038/ncomms6120.
«Directed evolution of high-affinity antibody mimics using mRNA display». Chem. Biol. 9: 933-42. 2002. PMID 12204693. doi:10.1016/s1074-5521(02)00187-4.
«FN3: a new protein scaffold reaches the clinic». Drug Discov. Today 14 (19–20): 949-55. July 2009. PMID 19576999. doi:10.1016/j.drudis.2009.06.007.
«Monobodies: antibody mimics based on the scaffold of the fibronectin type III domain». Methods Mol. Biol. 352: 95-109. 2007. PMID 17041261. doi:10.1385/1-59745-187-8:95.